Table 4.
PD-L1 expression and T cell infiltration in tumors before and after AdV-tk + prodrug
Dose level | Case # | PD-L1 | CD4 | CD8a | |||||
---|---|---|---|---|---|---|---|---|---|
Pre | Post | Prea | Posta | Fold change | Prea | Posta | Fold change | ||
1 | 1A03 | − | ++ | 0.67 | 1.67 | 2.49 | 4 | 31.33 | 7.83 |
2 | 2A02 | − | ++ | 4 | 9 | 2.25 | 1.67 | 55 | 32.93 |
3 | 3A01 | + | + | 1.33 | 0.33 | 0.25 | 1.67 | 125 | 74.85 |
3 | 3A02 | + | +++ | 3 | 1.67 | 0.56 | 4.33 | 48.33 | 11.16 |
3 | 3A03 | + | +++ | 9.67 | 7.33 | 0.76 | 8 | 98.33 | 12.29 |
4 | 4A01 | + | + | 8.33 | 5 | 0.60 | 6 | 39.33 | 6.56 |
4 | 4A02 | − | +++ | 3.33 | 7.67 | 2.30 | 6.33 | 38 | 6.00 |
Average CD4 change: 1.32 | Average CD8 change: 21.66 |
aAverage number of positive cells in three high-powered fields before (pre) or after (post) AdV-tk + prodrug